RCT Comparing OAGB and Long Limb Roux Gastric Bypass
- Conditions
- Obesity
- Interventions
- Procedure: One-anastomosis gastric bypassProcedure: Long biliary limb Roux gastric bypass
- Registration Number
- NCT04812132
- Lead Sponsor
- Tartu University Hospital
- Brief Summary
A prospective multicenter randomized controlled trial to compare the outcomes of one-anastomosis gastric bypass to long biliary limb Roux gastric bypass.
We plan to enroll up to 500 patients from three different clinics in Estonia. Outcomes are excess weight loss %, impact on type 2 diabetes, hypertension, hyperlipidemia and obstructive sleep apnea.
Other outcomes are nutritional deficiencies, occurrence of reflux disease and impact on quality of life.
There are planned outpatient visits 1, 5 and 10 years after the surgery to measure the impacts.
There are a lot of studies comparing OAGB to standard Roux gastric bypass but non comparing it to long biliary limb gastric bypass.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 500
- BMI over 35 and obesity related disease
- BMI over 40
- age between 18-60 years
- agrees to participate in the study
- age under 18 years or over 60 years
- abundant adhesions discovered during the surgery
- active upper gastrointestinal ulcer disease
- prior bariatric surgery
- active symptomatic reflux disease
- active psychiatric disease (eg psychosis)
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Men One-anastomosis gastric bypass - Women Long biliary limb Roux gastric bypass - Men Long biliary limb Roux gastric bypass - Women One-anastomosis gastric bypass -
- Primary Outcome Measures
Name Time Method Impact on total cholesterol 10 years Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol (mmol/L).
Impact on hypertensive disease 10 years Outcome of hypertensive disease after the surgery; measured in antihypertensive drug usage (same, decrease, ended)
Impact on type 2 diabetes mellitus 10 years Outcome of type 2 diabetes mellitus after the surgery, measured in usage of medication (same dosage, decreased dosage, insulin to peroral, ended all medication)
Impact on hyperlipidemia 10 years Outcome of hyperlipidemias after the surgery, measured in change in levels of triglycerides (mmol/L)
Impact on hyperlipidemias 10 years Outcome of hyperlipidemias after the surgery, measured in change in levels of total cholesterol, HDL,LDL and triglycerides
Excess weight loss % 10 years Calculated loss of the excess weight
- Secondary Outcome Measures
Name Time Method Nutritional deficiencies: anemia 10 years % of subjects having hemoglobin below sex adjusted reference (g/L) and ferritin below sex adjusted references (ug/L)
GERD 10 years % of subjects reporting reflux disease symptoms and/or PPI usage after the surgery
Nutritional deficiencies 10 years Occurrence of B12 deficiency, measured in % of subjects with vitamin B12 below reference (measures in pmol/L)
Trial Locations
- Locations (1)
Tartu University Hospital
🇪🇪Tartu, Estonia